ASX:SPL

Email Alerts for:
ASX:SPL

Cochlear (ASX:COH) appoints former Fisher & Paykel CEO to the board: ASX closed 0.3% lower

10 Dec 2019 - It has been a rollercoaster day of trade for the ASX. The local bourse managed to close 0.3% lower. Companies to lose the most ground were Avita Medical (ASX:AVH), Me…

Starpharma's (ASX:SPL) cancer drug progresses to stage 2 trials

10 Dec 2019 - Starpharma's (ASX:SPL) prostate cancer drug DEP cabazitaxel has successfully completed its phase one trials.

Starpharma (ASX:SPL) granted marketing approval for condom in Europe

21 Nov 2019 - Starpharma (ASX:SPL) has been granted marketing approval for the VivaGel® condom in Europe.

Starpharma's (ASX:SPL) drug proves effective in human pancreatic cancer model

31 Oct 2019 - Starpharma (ASX:SPL) says their next internal development candidate, DEP® gemcitabine significantly enhanced anti-tumour activity compared with Gemzar® both alone and…

Blackmores shares on the up once again: ASX tracking 0.5% higher at noon

12 Sep 2019 - The ASX opened higher and followed on from Wall Street as shares gained in early trading led by the technology sector. The market is now tracking 0.5% higher at noon.…

Starpharma VivaGel regulatory approvals continue in Asia

03 Sep 2019 - Starpharma (ASX:SPL) has today announced that it has received a further regulatory approval in another Asian country for its product VivaGel® BV.

Starpharma see positive results in ovarian cancer treatment

29 Aug 2019 - Starpharma (ASX:SPL) has seen positive results with targeted DEO using antibody fragment in human ovarian cancer model.

Starpharma signs second oncology agreement with AstraZeneca

03 Jun 2019 - Starpharma (ASX:SPL) has today announced a Development and Option Agreement with AstraZeneca to progress the development (of a Dendrimer Enhanced Product (DEP) versio…

ANZ Hospitals set to acquire Healthscope: Aus shares up 1.4% over week

24 May 2019 - After 6 sessions of gains the ASX200 took losses on Thursday and again today, closing 1.4% lower. Over the week the Finance sector capped the most gains and is up app…

Starpharma see impressive results for colon cancer drug

24 May 2019 - Starpharma (ASX:SPL) have released impressive results for their DEP irinotecan nanoparticle formulation for colon cancer.

China's Manufacturing PMI causes concern: ASX closes 1.6% lower

02 Jan 2019 - Australian shares took a dive this afternoon after China's December manufacturing report disappointed – more on this later. Commonwealth Bank is leading the market lo…

Starpharma's VivaGel® condom receives approval in Japan

02 Jan 2019 - Biotech company Starpharma (ASX:SPL) has today announced that the VivaGel® condom has received final regulatory approval and is now able to be marketed in Japan.

Christmas holiday week ends on the up: ASX closes 1.02% higher

28 Dec 2018 - It has been a positive day of trade for the Australian share market as the market closed in positive territory. Most of this week's gains came on Thursday. The big fo…

FDA request more data for Starpharma's infection gel approval

28 Dec 2018 - Biotech company Starpharma (ASX:SPL) has received advice from the US Food and Drug Administration that it will require more clinical data prior to approving VivaGel® …

Starpharma sees impressive new data published

31 Aug 2018 - Pharmaceutical Starpharma (ASX:SPL) today announced impressive data from AstraZeneca published by the World Intellectual Property Organisation.

Steady rise for ASX: Aus shares close 0.2 per cent higher

09 Jul 2018 - The Australian share market managed to stay modestly higher today after opening on a high this morning. Pilbara Minerals (ASX:PLS) saw a rise – of 5.9 per cent. Vocu…

CBA approaches my support level

26 Mar 2018 - Fairmont Equities managing director Michael Gable takes a technical look at Commonwealth Bank of Australia, Starpharma Holdings, Emeco Holdings, Stanmore Coal, Redbub…

Tuesday turnaround: Aus shares 0.1% higher at noon

21 Nov 2017 - Tuesday turnaround: Aus shares 0.1% higher at noon. Australia's 'Yes' vote bumps up consumer confidence, Kathmandu (ASX:KMD) releases Q1 financial results, Starpharma…

Starpharma receives TGA approval for VivaGel

25 Oct 2017 - A developer of dendrimer products, Starpharma (ASX:SPL) has received Australian marketing approval from the Therapeutic Goods of Administration (TGA) for its product,…

These stocks are ready to rally

18 Sep 2017 - Fairmont Equities managing director Michael Gable takes a technical look at Eclipx Group, Galaxy Resources, Pro Medicus, Nanosonics, Lynas Corp, Starpharma Holdings a…

Starpharma Holdings (ASX:SPL) discusses its dendrimer portfolio

01 Sep 2017 - Starpharma Holdings Limited (ASX:SPL) CEO Dr Jackie Fairley discusses the company's dendrimer portfolio, collaborations and agreement with AstraZeneca (NYSE:AZN).

Starpharma Holdings (ASX:SPL) Presentation, FNN Investor Event, August 2017, Sydney

01 Sep 2017 - Starpharma Holdings (ASX:SPL) CEO Dr Jackie Fairley discusses the company's recent successful Phase 3 results for its VivaGel® BV for treatment of recurrent bacterial…

Qantas management turbulence: Aus shares 0.68% lower at noon

28 Aug 2017 - Qantas management turbulence: Aus shares 0.68% lower at noon. Starpharma Holdings Limited (ASX:SPL) has reported a rebound into positive result territory, with its at…

Healthy finish: Aus shares close 1.06% higher

14 Jun 2017 - Healthy finish: Aus shares close 1.06% higher. Slater and Gordon Limited (ASX:SGH) has announced that an in principle agreement has been reached to settle the Manus …

Starpharma sells Agrochemicals business for $35M

14 Jun 2017 - Starpharma Holdings (ASX:SPL) completes a transaction to sell Starpharma Agrochemicals to Agrium Inc. for AUD$35 million in cash consideration.